mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy.
Cell Rep Med
; : 100978, 2023 Mar 17.
Article
in En
| MEDLINE
| ID: mdl-36933554
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
Cell Rep Med
Year:
2023
Type:
Article
Affiliation country:
Spain